首页>
外文期刊>Human gene therapy
>A first-in-human phase I/II trial demonstrates the safety and the immunogenicity of a lentiviral-based therapeutic HIV vaccine eliciting potent polyfunctional multispecific CD8 and CD4 T-cell responses in HIV-infected individuals
【24h】
A first-in-human phase I/II trial demonstrates the safety and the immunogenicity of a lentiviral-based therapeutic HIV vaccine eliciting potent polyfunctional multispecific CD8 and CD4 T-cell responses in HIV-infected individuals
展开▼
机译：一项首次人体 I/II 期试验证明了基于慢病毒的治疗性 HIV 疫苗在 HIV 感染者中引发有效的多功能多特异性 CD8 和 CD4 T 细胞反应的安全性和免疫原性
